TORONTO—(BUSINESS WIRE)—Muse has achieved a significant milestone with the launch of the Muse S Athena, the first wearable device to integrate clinical-grade EEG, fNIRS, and SpO₂ technologies into a lightweight, user-friendly design. This innovation represents a critical step towards Muse's broader vision of turning wearables into powerful, AI-driven platforms for brain health diagnostics. The Muse S Athena combines real-time biosignal data with advanced foundation models, similar to those used in cutting-edge language processing systems like GPTs. This integration allows the device to deliver expert-level insights directly to consumers, providing them with detailed information about their sleep quality and brain health. EEG (electroencephalography) measures electrical activity in the brain, offering valuable data about sleep cycles and cognitive functions. fNIRS (functional near-infrared spectroscopy) monitors brain oxygenation levels, which can indicate neural activity and overall brain health. SpO₂ (blood oxygen saturation) measurements help track cardiovascular and respiratory health during sleep. Together, these technologies create a comprehensive picture of an individual's physiological state, offering deeper insights than any single measurement alone. Muse's commitment to AI technology enhances the platform's capabilities. The AI algorithms process the data collected from the sensors, identifying patterns and providing personalized recommendations. This approach not only makes the information more accessible but also empowers users to take proactive steps in managing their brain health and sleep. One of the key features of the Muse S Athena is its ability to offer real-time feedback. For instance, if the device detects irregular brain wave activity or low blood oxygen saturation, it can immediately alert the user, allowing for timely interventions. Additionally, the platform's user interface is designed to be intuitive and easy to navigate, making it practical for everyday use. The implications of this technology extend beyond individual health. Researchers and medical professionals can leverage the Muse S Athena to gather large amounts of high-quality data, aiding in the development of new treatments and diagnostics. This potential for scalability and widespread adoption could revolutionize how brain health and sleep disorders are managed. Muse's CEO, Ariel Garten, emphasized the importance of this advancement: "We are excited to bring clinical-grade technology to the consumer market. The Muse S Athena not only offers unprecedented insights into sleep and brain health but also sets a new standard for wearables, demonstrating that cutting-edge medical tools can be both sophisticated and user-friendly." In a field where precision is paramount, the introduction of the Muse S Athena marks a significant leap forward. Its ability to continuously monitor and analyze multiple physiological signals in real time provides a level of detail that was previously difficult to achieve outside of a laboratory setting. This technology has the potential to enhance the lives of millions by offering personalized, actionable health data and recommendations. As the demand for wearable health technologies continues to grow, the Muse S Athena positions itself as a leader in the industry. Its unique combination of high-tech sensors and advanced AI algorithms sets it apart from other devices on the market. Early reviews have been positive, highlighting the device's accuracy and ease of use. The future of health and wellness may well rest on platforms like the Muse S Athena, which blend clinical expertise with the convenience of modern wearables. By making such advanced technology accessible to the general public, Muse is paving the way for a more informed and proactive approach to brain health and well-being.